PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
12-Apr-2022 Nouscom Announces New Translational Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine for the Treatment of MSI-H Solid Tumors, at AACR 2022 Nouscom
12-Apr-2022 European Patent Granted for Sareum’s SDC-1802, a Novel Small Molecule TYK2/JAK1 Inhibitor, for the Treatment of T-cell Acute Lymphoblastic Leukaemia Sareum Holdings
12-Apr-2022 Cline successfully completes first stage of StemCART ex-vivo testing on human cartilage Cline Scientific
12-Apr-2022 Revolutionary UK machine learning biotech firm agrees deal to develop new cancer treatments Etcembly
12-Apr-2022 Qlucore makes strategic recruitment for the clinical market Qlucore
12-Apr-2022 Early cancer diagnostic test, the Cytosponge, receives ACG backing for the screening of Barrett’s Esophagus Cytosponge
11-Apr-2022 CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities CluePoints
11-Apr-2022 Abzena Opens a New Biologics Testing Lab to Support Partners Programs Abzena
07-Apr-2022 STEMart Introduces Acute Systemic Toxicity Testing Service for Medical Devices STEMart
07-Apr-2022 CD BioSciences Launches Metabolic Signaling Pathways for Research Use CD BioSciences
06-Apr-2022 FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA SMi Group
06-Apr-2022 Early access issued for eligible patients in the UK for radioligand therapy in advanced prostate cancer Advanced Accelerator Applications (AAA), a Novartis company.
05-Apr-2022 Achilles Therapeutics to Host KOL Webcast to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting Achilles Therapeutics
05-Apr-2022 New centre targets ‘undruggable’ cancers after major donation ICR
05-Apr-2022 DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy Vifor Pharma
05-Apr-2022 FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis Regeneron
05-Apr-2022 AI test could predict effective cancer drug combinations in less than two days ICR
05-Apr-2022 AstraZeneca Announces Results from ETESIAN Phase IIb trial AstraZeneca
05-Apr-2022 Beckley Psytech announces dosing of first healthy volunteers in Phase 1 clinical trial assessing safety and pharmacokinetics of second innovative formulation of 5-MeO-DMT Beckley Psytech
05-Apr-2022 In-person kick-off meeting of the Eurostars-funded REPRINT Asgard Therapeutics